dr. figlin on considerations for combining tkis and immunotherapy in rcc
Published 5 years ago • 47 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:32
dr. figlin on promise of immunotherapy plus tki combinations in rcc
-
1:15
dr. figlin on toxicity profile of immunotherapy/vegf tki combinations in rcc
-
1:44
dr. figlin discusses sequencing mtor inhibitors and tkis in rcc
-
1:18
dr. figlin on treatment strategies in advanced rcc
-
1:54
dr. figlin on tki therapy options in renal cell carcinoma
-
0:59
dr. figlin discusses future of rcc treatment
-
0:53
dr. figlin on advances in immunotherapy for kidney cancer
-
1:02
dr. figlin on advice for oncologists treating rcc
-
1:35
dr. grigg on immunotherapy/tki combinations in rcc
-
1:15
dr. figlin on the plethora of novel agents in rcc
-
1:15
dr. mcdermott on single-agent versus combination immunotherapy in rcc
-
1:24
dr. figlin on sunitinib for patients with rcc
-
1:25
dr. figlin discusses the future of kidney cancer treatment
-
1:17
dr. figlin on the evolving treatment landscape of renal cell carcinoma
-
1:57
dr. robert figlin on the increasingly complicated treatment paradigm for renal cell carcinoma
-
2:16
dr. amin on toxicities with immunotherapy/tki combinations in rcc
-
1:25
dr. figlin on ongoing adapt trial for mrcc
-
1:38
dr. robert figlin on the future of treatment for patients with rcc
-
0:59
dr. alva on tki monotherapy and combinations for rcc